Cholera vaccine shortage forces one-dose strategy: WHO
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma